PGEN - Company ID 0001356090
The table below shows PRECIGEN, INC.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $9.68M | $3.92M | $6.22M | $26.91M | $14.27M | $31.99M |
| Cost of revenue | - | - | - | - | - | - |
| Gross profit | - | - | - | - | - | - |
| R&D | $41.33M | $53.07M | $48.61M | - | - | - |
| SG&A |
PRECIGEN, INC. reported annual revenue of $9.68M for fiscal year 2025. That is up 146.7% from $3.92M in fiscal 2024. Over the 10 fiscal years shown, annual revenue declined from $190.93M (FY 2016) to $9.68M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $70.13M |
| $41.29M |
| $40.41M |
| - |
| - |
| - |
| Operating income | -$110.51M | -$135.03M | -$99.76M | - | - | - |
| Income tax | $3.00K | -$1.79M | -$458.00K | -$189.00K | -$160.00K | -$82.00K |
| Net income | -$250.60M | -$126.20M | -$95.90M | $28.30M | -$92.20M | -$170.52M |
| EPS (diluted) | -$1.37 | -$0.47 | -$0.39 | $0.14 | -$0.47 | -$1.02 |